RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Vastus lateralis myofascial free flap for tongue reconstruction and hypoglossal-femoral anastomosis: neurophysiological study
2019-01-01 Galiè, E.; Villani, V.; Ferreli, F; Pace, A.; Pellini, R.
Vastus lateralis myofascial free flap in tongue reconstruction
2016-01-01 Pellini, R; De Virgilio, A; Mercante, G; Pichi, B; Manciocco, V; Marchesi, P; Ferreli, F; Spriano, G
Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?
2020-01-01 D'Amico, Ferdinando; Danese, Silvio; Peyrin-Biroulet, Laurent
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013-01-01 Feagan, Bg; Rutgeerts, P; Sands, Be; Hanauer, S; Colombel, Jf; Sandborn, Wj; Van Assche, G; Axler, J; Kim, Hj; Danese, S; Fox, I; Milch, C; Sankoh, S; Wyant, T; Xu, J; Parikh, A
Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn's Disease or Ulcerative Colitis
2020-01-01 Vermeire, Séverine; Lukáš, Milan; Magro, Fernando; Adsul, Shashi; Lindner, Dirk; Rosario, Maria; Roth, Jeannine; Danese, Silvio
Vedolizumab for the treatment of Crohn's disease
2018-01-01 Argollo, M; Fiorino, G; Peyrin-Biroulet, L; Danese, S
Vedolizumab for the Treatment of IBD: A Selective Therapeutic Approach Targeting Pathogenic a4b7 Cells
2013-01-01 Jovani, M; Danese, S
Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing
2019-01-01 D'Amico, F; Fiorino, G; Peyrin-Biroulet, L; Danese, S
Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review
2019-01-01 Chateau, T; Bonovas, S; Le Berre, C; Mathieu, N; Danese, S; Peyrin-Biroulet, L
Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis
2019-01-01 Pouillon, L; Rousseau, H; Busby-Venner, H; Bittencourt, Md; Choukour, M; Gauchotte, G; Zallot, C; Danese, S; Baumann, C; Peyrin-Biroulet, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Vastus lateralis myofascial free flap for tongue reconstruction and hypoglossal-femoral anastomosis: neurophysiological study | 1-gen-2019 | Galiè, E.; Villani, V.; Ferreli, F; Pace, A.; Pellini, R. | |
| Vastus lateralis myofascial free flap in tongue reconstruction | 1-gen-2016 | Pellini, R; De Virgilio, A; Mercante, G; Pichi, B; Manciocco, V; Marchesi, P; Ferreli, F; Spriano, G | |
| Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins? | 1-gen-2020 | D'Amico, Ferdinando; Danese, Silvio; Peyrin-Biroulet, Laurent | |
| Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis | 1-gen-2013 | Feagan, Bg; Rutgeerts, P; Sands, Be; Hanauer, S; Colombel, Jf; Sandborn, Wj; Van Assche, G; Axler, J; Kim, Hj; Danese, S; Fox, I; Milch, C; Sankoh, S; Wyant, T; Xu, J; Parikh, A | |
| Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn's Disease or Ulcerative Colitis | 1-gen-2020 | Vermeire, Séverine; Lukáš, Milan; Magro, Fernando; Adsul, Shashi; Lindner, Dirk; Rosario, Maria; Roth, Jeannine; Danese, Silvio | |
| Vedolizumab for the treatment of Crohn's disease | 1-gen-2018 | Argollo, M; Fiorino, G; Peyrin-Biroulet, L; Danese, S | |
| Vedolizumab for the Treatment of IBD: A Selective Therapeutic Approach Targeting Pathogenic a4b7 Cells | 1-gen-2013 | Jovani, M; Danese, S | |
| Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing | 1-gen-2019 | D'Amico, F; Fiorino, G; Peyrin-Biroulet, L; Danese, S | |
| Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review | 1-gen-2019 | Chateau, T; Bonovas, S; Le Berre, C; Mathieu, N; Danese, S; Peyrin-Biroulet, L | |
| Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis | 1-gen-2019 | Pouillon, L; Rousseau, H; Busby-Venner, H; Bittencourt, Md; Choukour, M; Gauchotte, G; Zallot, C; Danese, S; Baumann, C; Peyrin-Biroulet, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 13108
- 1 Contributo su Rivista::1.1 Arti... 11508
- 1 Contributo su Rivista::1.5 Abst... 1257
- 1 Contributo su Rivista::1.2 Rece... 151
- 1 Contributo su Rivista::1.8 Mate... 142
- 1 Contributo su Rivista::1.7 Lettera 42
- 1 Contributo su Rivista::1.4 Nota... 8
Data di pubblicazione
- 2020 1514
- 2019 1422
- 2018 1308
- 2017 1369
- 2016 1317
- 2015 1153
- 2014 1074
- 2013 991
- 2012 1050
- 2011 958
Editore
- Nature Publishing Group 3
- s.n 3
- Elsevier 1
- Thieme 1
Rivista
- DIGESTIVE AND LIVER DISEASE 295
- EUROPEAN JOURNAL OF NUCLEAR MEDIC... 220
- THE JOURNAL OF UROLOGY 174
- GASTROINTESTINAL ENDOSCOPY 166
- PLOS ONE 145
- GASTROENTEROLOGY 141
- THE JOURNAL OF NUCLEAR MEDICINE 131
- ANNALS OF ONCOLOGY 127
- JOURNAL OF CROHN'S AND COLITIS 126
- KNEE SURGERY, SPORTS TRAUMATOLOGY... 124
Keyword
- Humans 1215
- Male 598
- Female 590
- Middle Aged 431
- Aged 399
- Adult 314
- Treatment Outcome 232
- Animals 208
- Italy 166
- Retrospective Studies 161
Lingua
- eng 7337
- ita 122
- und 5
- fre 4
- spa 2
- ger 1
Accesso al fulltext
- no fulltext 11938
- reserved 949
- open 221